Quick Answer
Burning Rock Biotech Ltd reported Net Income of -$346.63 million for fiscal year 2024.
Burning Rock Biotech Ltd Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$346.63M | +47.0% |
| 2023 | -$653.69M | +32.7% |
| 2022 | -$971.23M | -21.9% |
| 2021 | -$796.70M | -95.6% |
| 2020 | -$407.24M | -140.7% |
| 2019 | -$169.16M | +4.7% |
| 2018 | -$177.50M | — |
- Burning Rock Biotech Ltd showed an increase of +47.0% in Net Income compared to the prior fiscal year.
- Over the 2018–2024 period, Burning Rock Biotech Ltd’s net income has declined by 95.3% (from -$177.50 million to -$346.63 million).
- The most recent figure is from Burning Rock Biotech Ltd’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: